SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr | ₹3,869 Cr |
What is the latest Total Debt ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹1,870 Cr |
| Mar2024 | ₹2,846 Cr |
| Mar2023 | ₹6,198 Cr |
| Mar2022 | ₹931 Cr |
| Mar2021 | ₹3,869 Cr |
How is Total Debt of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,870 Cr | -34.30 | |
| Mar2024 | ₹2,846 Cr | -54.09 | |
| Mar2023 | ₹6,198 Cr | 565.94 | |
| Mar2022 | ₹931 Cr | -75.94 | |
| Mar2021 | ₹3,869 Cr | - | |
Compare Total Debt of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,656.3 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| MANKIND PHARMA | ₹93,324.0 Cr | -0.9% | 10.1% | -11.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 11.6% |
0.7% |
-0.4% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses